AI
Monday, November 03, 2025 11:55:03 AM
seekazy,
Thanks for reposting to highlight this topic again 😶
Some readers on the board might not be aware of the two highly significant recent combo studies at UCLA—one completed and published in Nature Comms, and the other that’s ongoing today…
Fact ✅️:
In a 2023 article published by UCLA, they cited the DC platform technology that was published in JAMA Oncology, and then added that the vaccine is now being studied in combo with checkpoint inhibitors. They also used the name DCVax-L.
In the Nature Comms publication, Northwest Biotherapeutics, Inc is named (typo/misspelling) in the Ethics Declarations section as the owner of the license.
Additionally, Dr. Liau is there to sort out any discrepancies, so you don’t have to be concerned anymore:
⭐️ AACR Advances in Ovarian Cancer Research
⭐️ NWBO to Acquire Advent BioServices
⭐️ Recent Conference
⭐️ DCVax-L Combo PII UCLA
⭐️ DC Combo PII Roswell Park
⭐️ 10-Q Quarterly Report
⭐️ 10-K Annual Report
⭐️ NICE UK 🇬🇧 DCVax-L
⭐️ ASM June 29, 2024
⭐️ Manufacturing Technology
⭐️ NWBO Acquires Flaskworks
⭐️ Roswell Park IP Portfolio
⭐️ TLR3 agonist Ampligen (rintatolimod)
⭐️ Next Generation Dendritic Cell Treatments
⭐️Combo is King!⭐️
AI Fact-Checking
Fud Flood 🌊
Thanks for reposting to highlight this topic again 😶
Some readers on the board might not be aware of the two highly significant recent combo studies at UCLA—one completed and published in Nature Comms, and the other that’s ongoing today…
Fact ✅️:
In a 2023 article published by UCLA, they cited the DC platform technology that was published in JAMA Oncology, and then added that the vaccine is now being studied in combo with checkpoint inhibitors. They also used the name DCVax-L.
In the Nature Comms publication, Northwest Biotherapeutics, Inc is named (typo/misspelling) in the Ethics Declarations section as the owner of the license.
Additionally, Dr. Liau is there to sort out any discrepancies, so you don’t have to be concerned anymore:
⭐️ AACR Advances in Ovarian Cancer Research
⭐️ NWBO to Acquire Advent BioServices
⭐️ Recent Conference
⭐️ DCVax-L Combo PII UCLA
⭐️ DC Combo PII Roswell Park
⭐️ 10-Q Quarterly Report
⭐️ 10-K Annual Report
⭐️ NICE UK 🇬🇧 DCVax-L
⭐️ ASM June 29, 2024
⭐️ Manufacturing Technology
⭐️ NWBO Acquires Flaskworks
⭐️ Roswell Park IP Portfolio
⭐️ TLR3 agonist Ampligen (rintatolimod)
⭐️ Next Generation Dendritic Cell Treatments
⭐️Combo is King!⭐️
AI Fact-Checking
Fud Flood 🌊
Bullish
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
